| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 5.7e-05 | 1 |